Search results
CymaBay Therapeutics Inc. (CBAY) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 2 years agoCymaBay Therapeutics Inc. (CBAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
CymaBay Therapeutics Inc. (CBAY) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks via Yahoo Finance· 11 months agoCymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a...
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 8 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...
Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates
Zacks via Yahoo Finance· 2 months agoIt has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...
Why CymaBay Morphed From Dollar Stock To Biotech Rocket
Investor's Business Daily· 4 months agoCymaBay Therapeutics is sprinting to the finish line with a breakthrough treatment for a serious...
Institutional investors own a significant stake of 45% in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies CymaBay Therapeutics' stock price is...
Trade Alert: The President Of CymaBay Therapeutics, Inc. (NASDAQ:CBAY), Sujal Shah, Has Just Spent...
Simply Wall St. via Yahoo Finance· 2 years agoPotential CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shareholders may wish to note that the President,...
Investing in CymaBay Therapeutics (NASDAQ:CBAY) three years ago would have delivered you a 540% gain
Simply Wall St. via Yahoo Finance· 2 months agoFor us, stock picking is in large part the hunt for the truly magnificent stocks. You won't get it...
CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 months agoCymaBay Therapeutics Inc. (CBAY) delivered earnings and revenue surprises of -9.38% and 85.75%,...
CymaBay Therapeutics Inc. (CBAY) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 2 years agoAfter reaching an important support level, CymaBay Therapeutics Inc. (CBAY) could be a good stock...